510(k) K212625

PathBuilder Transseptal Needle by Shanghai Microport EP Medtech Co., Ltd. — Product Code DRC

K212625 is an FDA 510(k) premarket notification submitted by Shanghai Microport EP Medtech Co., Ltd. for the device "PathBuilder Transseptal Needle". The FDA issued a decision of Substantially Equivalent on Mar 23, 2022. The device falls under product code DRC (Trocar), a Class II device regulated under 21 CFR 870.1390. Shanghai Microport EP Medtech Co., Ltd. has 3 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Mar 23, 2022
Date Received
Aug 18, 2021
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Trocar
Device Class
Class II
Regulation Number
870.1390
Review Panel
CV
Submission Type
510(k) Exempt

Need the full FDA record for Shanghai Microport EP Medtech Co., Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K212625. Report a data issue: hello@regdatalab.com.